Cell Science

Fluorescent Immunohistochemistry
#Assays #Cell Science #Drug discovery #Drug targets #Immunohistochemistry

Find validated IHC and mIF markers for your target before your study starts

This new free download can help researchers avoid assay development delays. Download this reference list from Crown Bioscience, which shows what is already validated and ready to run. You will learn: 500+ Human IHC markers for RUO, IVD or CDx Prevalidated 5 to 7-color mIF panels suitable for IO and… Read More

#News

T cell engagers
#Cell Science #Drug discovery #T cell engagers #Whitepaper

Whitepaper – T-cell engagers: From drug discovery hurdles to next-gen solutions

Read this new Whitepaper from WuXi Biologics. Innovative platforms across key stages of TCE drug discovery, with real-world case studies on high-purity production and fit-for-purpose in vitro & in vivo studies. Proven approaches to navigate key development challenges, such as structural complexity, CRS risks, and tumour heterogeneity. Forward-looking strategies combining… Read More

#News

#Biologics #Cell Science #Drug discovery #Stability characterisation

Stop settling for the proxy – Why stability tests for biologics should measure intermolecular interactions directly

In this advertorial, Dr John Stenson from Malvern Panalytical explains why we need to move away from using ‘SLS mode’ on DLS instruments to determine B22 stability values for biologics. Reliable stability data: A growing need Stability testing for biologics is undergoing something of a revolution, with the introduction of… Read More

#Exclusive Content

Human liver
#Cell Science #Drug discovery #New approach methodologies (NAMs) #Organoids #Preclinical development

Download the Factsheet: MASLD research needs better liver models

A new resource is now available to download for free. MASLD drug development is limited by models that don’t reflect human liver biology. HUB’s patient-derived liver organoids retain donor genetics, architecture and physiology. Download the Factsheet to learn: How organoids recapitulate steatosis and fibrosis Which readouts support target validation… Read More

#News

#App note #Cell Science #Drug discovery #Life sciences #Live cell analysis #Spheroid

App Note: Go beyond 2D with 3D live-cell technologies

Boost your drug discovery with 3D spheroid models and live-cell analysis – perfect for screening thousands of compounds! A new App Note is now available from Sartorius entitled ‘Enhance Drug Discovery: Utilising a 3D Spheroid Model and Live-Cell Analysis for Compound Profiling’. Download the App Note to learn: How… Read More

#News

#Cell Science #Drug discovery #Organoids #Protein #Stem cells #Vaccines

How new scientific approaches are accelerating R&D

This is the latest episode of the free DDW Narrated Podcast, called “How new scientific approaches are accelerating R&D”. The episode covers two articles written for DDW Volume 25, Issue 1, Winter 2023/24. The first article is called ‘Accelerating recombinant protein vaccine discovery’. In the… Read More

#Featured Podcasts #Podcasts

#App note #Cell Science #Drug discovery #Life sciences #Live cell analysis #Spheroid

Transform compound screening – Go beyond 2D with 3D live-cell technologies

Boost your drug discovery with 3D spheroid models and live-cell analysis – perfect for screening thousands of compounds! Download the App Note to learn: How to capture dynamic cellular changes in real time How to understand the advantages of 3D assays over traditional 2D models About advanced imaging and analysis… Read More

#App Notes #Resources

#3D imaging #3D modelling #Cell Science #Drug discovery #eBook #Live cell analysis #Oncology #Spheroid

eBook: Unlock the full potential of spheroid models in research

3D spheroid models and live-cell analysis are powerful tools transforming drug discovery and cancer science. Download this eBook ‘Exploring the Versatility of Using 3D Spheroid Models in Research‘ from Sartorius to learn: How real-time imaging unlocks deeper insights Discover why 3D models outperform traditional cultures How to create more… Read More

#News

#3D imaging #3D modelling #Cell Science #Drug discovery #eBook #Live cell analysis #Oncology #Spheroid

Go beyond 2D – Unlock the full potential of spheroid models in research

3D spheroid models and live-cell analysis – powerful tools transforming drug discovery and cancer science! Download the eBook to learn: How real-time imaging unlocks deeper insights Discover why 3D models outperform traditional cultures How to create more reliable, clinically relevant cancer models Download now and accelerate your breakthroughs.  … Read More

#eBooks #Resources

#Cell Science #Drug discovery #Genetics / genomics #Spatial biology

3D spatial biology: A new dimension for drug discovery

Dr Todd Dickinson, CEO, Stellaromics on 3D spatial biology and functional genomics. Understanding how genes are regulated and expressed in complex tissue environments is fundamental to modern drug discovery. Traditionally, researchers have relied on 2D spatial genomics methods, analysing thin slices of tissue on a single plane to study gene… Read More

#Exclusive Content

Human heart
#3D modelling #Cell Science #Drug discovery #Drug toxicity #High throughput screening #Screening #Webinar

Last chance: The benefits of 3D cardiac microtissue models

Balancing assay throughput with physiological relevance is essential for improving disease modelling and compound screening in preclinical drug development. Induced pluripotent stem cell (iPSC) technology has revolutionised early drug discovery by integrating human biology, enhancing predictions of drug safety and efficacy. However, achieving both scalability and consistency in… Read More

Webinar date:
Supported by Ncardia
#News

#3D modelling #Cell Science #Drug discovery #Drug toxicity #High throughput screening #Screening #Webinar

Webinar: Advancing cardiotoxicity studies with 3D models

Balancing assay throughput with physiological relevance is essential for improving disease modelling and compound screening in preclinical drug development. Induced pluripotent stem cell (iPSC) technology has revolutionised early drug discovery by integrating human biology, enhancing predictions of drug safety and efficacy. However, achieving both scalability and consistency in… Read More

Webinar date:
Supported by Ncardia
#News

Heart
#3D modelling #Cell Science #Drug discovery #Drug toxicity #High throughput screening #Screening #Webinar

Webinar: Cardiac screening with physiologically relevant 3D models

Balancing assay throughput with physiological relevance is essential for improving disease modelling and compound screening in preclinical drug development. Induced pluripotent stem cell (iPSC) technology has revolutionised early drug discovery by integrating human biology, enhancing predictions of drug safety and efficacy. However, achieving both scalability and consistency in… Read More

Webinar date:
Supported by Ncardia
#News

Cardiovascular system
#3D modelling #Cell Science #Drug discovery #Drug toxicity #High throughput screening #Screening #Webinar

Webinar: How can 3D cardiac models advance drug screening?

Balancing assay throughput with physiological relevance is essential for improving disease modelling and compound screening in preclinical drug development. Induced pluripotent stem cell (iPSC) technology has revolutionised early drug discovery by integrating human biology, enhancing predictions of drug safety and efficacy. However, achieving both scalability and consistency in… Read More

Webinar date:
Supported by Ncardia
#News

Human heart
#3D modelling #Cell Science #Drug discovery #Drug toxicity #High throughput screening #Screening #Webinar

Watch now: Streamline high-throughput cardiac screening

Balancing assay throughput with physiological relevance is essential for improving disease modelling and compound screening in preclinical drug development. Induced pluripotent stem cell (iPSC) technology has revolutionised early drug discovery by integrating human biology, enhancing predictions of drug safety and efficacy. However, achieving both scalability and consistency in… Read More

Webinar date:
Supported by Ncardia
#News

#3D cell culture #Cell Science #Drug discovery #Organoids #Stem cells

Pushing drug discovery with stem cells, organoids and 3D cell cultures

DDW Editor Reece Armstrong looks at how advances in stem cells, organoids and 3D cell cultures are affecting drug discovery and development.  Stem cells, organoids and 3D cell cultures have emerged as promising tools that scientists can use to better understand disease and how drugs function within the human body. … Read More

#Exclusive Content